New tests will improve detection of latent TB

Practitioner

Volumn 255, Issue 1745, 2011, Pages 23-26

  Chapman, Ann L N ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; TUBERCULIN TEST;

HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; TUBERCULIN TEST;

EID: 84856250355     PISSN: 00326518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Global Tuberculosis Control: World Health Organization report 2011 www.who.int/tb/publications/global-report/2011/gtbr11-full.pdf
2. Health Protection Agency. Tuberculosis in the UK: Annual report on tuberculosis surveillance in the UK 2010 www.hpa.org.uk/web/HPAweb & HPAwebStandard/HPAweb-C/1287143581697
3. Pai M. Spectrum of latent tuberculosis - existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010;8:242
4. Department of Health. Stopping Tuberculosis in England: An Action Plan from the Chief Medical Officer. DH. London. 2004
5. Boehme CC, Nabeta P, Hillemann D et al. Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med 2010;363:1005-15
6. Walzl G, Ronacher K, Hanekom W et al. Immunological biomarkers of tuberculosis. Nature Rev Immunol 2011;11:343-354
7. Nelson SM, Deike MA, Cartwright CP. Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol 1998;36:467-9 (Pubitemid 28060314)
8. Metcalf EP, Davies JC, Wood F et al. Unwrapping the diagnosis of tuberculosis in primary care: a qualitative study. Br J Gen Pract 2007;57:116-22 (Pubitemid 46242536)
9. Lalvani A, Pathan AA, McShane H et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Resp Crit Care Med 2001;163:824-8 (Pubitemid 32275850)
10. Brock I, Munk ME, Kok-Jensen A, Anderson P. Performance of whole blood IFN-γ test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 2001;5:462-7 (Pubitemid 32397571)
11. Diel R, Goletti D, Ferrara G et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: A systematic review and metaanalysis. Eur Resp J 2011;37:88-99
12. Richeldi L, Losi M, D'Amico R et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009;136:198-204
13. Dheda K, van Zyl Smit R, Badri M, Pai M. T-cell interferongamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings. Curr Opin Pulm Med 2009;15:188-200
14. Pareek M, Watson JP, Ormerod LP et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis 2011;11(6):435-44
15. Department of Health. Tuberculosis prevention and treatment: a toolkit for planning, commissioning and delivering high-quality services in England. DH. London. 2007
16. National Institute for Health and Clinical Excellence. CG117. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. NICE. London. 2011
17. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000;2:CD001363
18. Diel R, Loddenkemper R, Meywald-Walter K et al. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am J Resp Crit Care Med 2008;177:1164-1170 (Pubitemid 351717577)